American Portfolios Advisors Ionis Pharmaceuticals Inc Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 300 shares of IONS stock, worth $10,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$10,095% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
132MCall Options Held
752KPut Options Held
741K-
Vanguard Group Inc Valley Forge, PA16.4MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$477 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$386 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$347 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$265 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.78B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...